Yoko Edahiro

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 10

Top Topics

Tyrosine Kinase

Endoplasmic Reticulum

Chronic Myeloid Leukemia

Top Venues

Hematology (Amsterdam, Netherlands)

Journal of thrombosis and thrombolysis

Japanese journal of clinical oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Yoko Edahiro, Tomonori Ochiai, Yoshinori Hashimoto, Michiko Ichii, Takeshi Okatani, Hiromi Omura, Kei Nakajima, Makoto Sasaki, Jun Ando, Tomoiku Takaku, Michiaki Koike, Koh Izumiyama, Junji Hiraga, Tomofumi Yano, Kensuke Usuki, Eiichi Ohtsuka, Kenji Yokoyama, Tatsuo Oyake, Naoki Takahashi, Tetsuya Nishida, Takafumi Nakao, Yasutaka Fukuda, Takashi Akasaka, Atsuko Mugitani, Miki Ando, Norio Komatsu
Real-world status of treatment for lymphoid neoplasms developed during the course of myeloproliferative neoplasms in Japan. Hematology (Amsterdam, Netherlands) 29 (1) (2024)
Yoko Edahiro, Tomonori Ochiai, Yoshinori Hashimoto, Michiko Ichii, Takeshi Okatani, Hiromi Omura, Kei Nakajima, Makoto Sasaki, Jun Ando, Tomoiku Takaku, Michiaki Koike, Koh Izumiyama, Junji Hiraga, Tomofumi Yano, Kensuke Usuki, Eiichi Ohtsuka, Kenji Yokoyama, Tatsuo Oyake, Naoki Takahashi, Tetsuya Nishida, Takafumi Nakao, Yasutaka Fukuda, Takashi Akasaka, Atsuko Mugitani, Miki Ando, Norio Komatsu
Real-world status of treatment for lymphoid neoplasms developed during the course of myeloproliferative neoplasms in Japan. Hematology (Amsterdam, Netherlands) 29 (1) (2024)
Chiho Furuya, Soji Morishita, Yoshinori Hashimoto, Tadaaki Inano, Tomonori Ochiai, Shuichi Shirane, Yoko Edahiro, Marito Araki, Miki Ando, Norio Komatsu
Impact of non-driver gene mutations on thrombo-haemorrhagic events in ET patients. British journal of haematology (2023)
Chiho Furuya, Yoshinori Hashimoto, Soji Morishita, Tadaaki Inano, Tomonori Ochiai, Shuichi Shirane, Yoko Edahiro, Marito Araki, Miki Ando, Norio Komatsu
MPL gene mutation is a possible risk factor for thrombosis in patients with essential thrombocythemia in Japan. Hematology (Amsterdam, Netherlands) 28 (1) (2023)
Soji Morishita, Yoshinori Hashimoto, Chiho Furuya, Yoko Edahiro, Tomonori Ochiai, Shuichi Shirane, Tadaaki Inano, Hajime Yasuda, Miki Ando, Marito Araki, Norio Komatsu
Non-driver gene mutation analysis in a large cohort of polycythemia vera and essential thrombocythemia. European journal of haematology (2022)
Yosuke Mori, Marito Araki, Soji Morishita, Misa Imai, Yoko Edahiro, Masafumi Ito, Tomonori Ochiai, Shuichi Shirane, Yoshinori Hashimoto, Hajime Yasuda, Jun Ando, Miki Ando, Norio Komatsu
Clinical features of acquired erythrocytosis: Low levels of serum erythropoietin in a subset of non-neoplastic erythrocytosis patients. Cancer medicine (2022)
Chiho Furuya, Yoshinori Hashimoto, Soji Morishita, Tadaaki Inano, Tomonori Ochiai, Shuichi Shirane, Yoko Edahiro, Marito Araki, Miki Ando, Norio Komatsu
Reevaluation of cardiovascular risk factors for thrombotic events in 580 Japanese patients with essential thrombocythemia. Journal of thrombosis and thrombolysis (2022)
Yoko Edahiro, Michiaki Koike, Shuko Nojiri, Yoshinao Harada, Akihiko Gotoh, Kazutoshi Fujibayashi, Yuji Nishizaki, Naotake Yanagisawa, Tomoiku Takaku, Hideaki Nitta, Yutaka Tsukune, Kyohei Misawa, Hiroyuki Kobayashi, Norio Komatsu
A pilot study examining the efficacy of hochuekkito for improving quality of life in patients with myeloproliferative neoplasms. Japanese journal of clinical oncology 52 (8) (2022)
Soji Morishita, Hajime Yasuda, Saya Yamawaki, Hideya Kawaji, Masayoshi Itoh, Yoko Edahiro, Misa Imai, Yasushi Kogo, Satoshi Tsuneda, Akimichi Ohsaka, Yoshihide Hayashizaki, Masafumi Ito, Marito Araki, Norio Komatsu
CREB3L1 overexpression as a potential diagnostic marker of Philadelphia chromosome-negative myeloproliferative neoplasms. Cancer science 112 (2) (2020)
Yoko Edahiro, Marito Araki, Norio Komatsu
Mechanism underlying the development of myeloproliferative neoplasms through mutant calreticulin. Cancer science 111 (8) (2020)